|
|
|
STEROID HORMONE BIOSYNTHETIC PATHWAY (PW:0000040)
DescriptionSteroid hormones play important roles in metabolism, growth and differentiation and in reproductive functions. The synthesis and release of steroid hormones are highly regulated by the hypothalamus-pituitary-adrenal axis. The precursor of all steroid hormones is cholesterol which is derived from diet or via de novo synthesis from acetyl-CoA. The chronic steroidogenic response involves the change in the expression of steroidogenic genes while the acute response involves the quick delivery of cholesterol to the site of the first enzymatic reaction. The rapid flux of cholesterol from the outer (OMM) to the inner (IMM) mitochondrial membrane is mediated by the StAR protein. The IMM is the site where Cyp11a1, the enzyme catalyzing the first and rate-limiting step in the steroid biosynthetic pathway, is located. Overall there are two major classes of enzymes: the heme-containing cytochrome P450 and the hydroxysteroid dehydrogenase enzymes. The members of the P450 superfamily that participate in the pathway are membrane-bound mitochondrial or endoplasmic reticulum (microsome) enzymes that utilize NADPH as an electron donor. Two proteins mediate the mitochondrial electron transfer - the flavin-containing Fdxr and the iron-sulfur Fdx1; only one protein mediates the microsomal electron transfer - the P450 (cytochrome) oxidoreductase Por with two flavin cofactors. Dehydrogenases are membrane-bound mitochondrial or microsomal enzymes that utilize NAD or NADPH depending on whether the reaction is oxidation or reduction. The 27-carbon cholesterol is converted to the C 21 pregnenolone in a series of three chemical reactions that together constitute the step catalyzed by Cyp11a1. From this point, the pathway diverges into the individual branches that lead to the synthesis of particular types of steroids at specific adrenal and gonadal locations. Pregnenolone is converted to progesterone, itself an important hormone, or to 17OH-pregnenolone by Hsd3b1 or Hsd3b2, and Cyp17a1, respectively. In the adrenal zona glomerulosa, progesterone is converted to the C 21 mineralocorticoid aldosterone via a number of steps in the aldosterone biosynthetic pathway. Either progesterone or 17OH-pregnenolone can lead to the formation of the C 21 glucocorticoid cortisol in the cortisol biosynthetic pathway in zona fasciculata. Cyp17a1 catalyzes both 17-hydroxylation and 17,20 lyase reactions. The lyase activity of the enzyme accounts for the formation of the C 19 androgen dehydroepiandrosterone DHEA in the zona reticularis. In the testosterone biosynthetic pathway, DHEA is converted to testosterone in the testis; in the beta-estradiol biosynthetic pathway, testosterone is converted to the C 18 estrogen estradiol in the ovaries. To see the ontology report for annotations, GViewer and download click here[click to see the ontology report for related GO term - GO:0006694, associated KEGG map - map00140 and related entry at Reactome - REACT_11057.2]
The steroid hormone biosynthetic pathway is part of the Steroid Hormone Biosynthesis Pathway Suite and the Prostate Cancer Pathway Suite. Click the name of the suite to view the related pathways. ...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
steroid hormone biosynthetic pathway
|
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
|
IEA |
4 |
64,972,908 |
65,005,896 |
RGD:6907045 |
KEGG |
| G |
Comt |
catechol-O-methyltransferase |
|
|
IEA |
11 |
84,561,591 |
84,581,713 |
RGD:6907045 |
KEGG |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
IEA |
8 |
61,793,976 |
61,805,308 |
RGD:6907045 |
KEGG |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,793,976 |
61,805,308 |
RGD:2325883 |
RGD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
|
IEA |
7 |
112,977,395 |
112,984,080 |
RGD:6907045 |
KEGG |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
IEA |
7 |
113,043,365 |
113,049,779 |
RGD:6907045 |
KEGG |
| G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
|
|
IEA |
7 |
113,013,335 |
113,018,824 |
RGD:6907045 |
KEGG |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
|
IEA |
1 |
251,965,458 |
251,971,449 |
RGD:6907045 |
KEGG |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
|
ISS |
1 |
251,965,458 |
251,971,449 |
RGD:2325883 |
RGD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
|
ISS |
|
|
|
RGD:4889549 |
RGD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
|
IEA |
|
|
|
RGD:6907045 |
KEGG |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
|
IEA |
8 |
61,462,207 |
61,468,237 |
RGD:6907045 |
KEGG |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
|
IEA |
6 |
2,548,224 |
2,553,767 |
RGD:6907045 |
KEGG |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
|
IEA |
20 |
4,125,357 |
4,128,518 |
RGD:6907045 |
KEGG |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
|
IEA |
12 |
9,086,752 |
9,136,606 |
RGD:6907045 |
KEGG |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
|
IEA |
12 |
9,517,016 |
9,541,000 |
RGD:6907045 |
KEGG |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
|
IEA |
12 |
9,567,120 |
9,595,974 |
RGD:6907045 |
KEGG |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
|
IEA |
12 |
17,164,384 |
17,204,589 |
RGD:6907045 |
KEGG |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
|
IEA |
5 |
19,707,159 |
19,716,856 |
RGD:6907045 |
KEGG |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
|
IEA |
2 |
103,102,679 |
103,271,273 |
RGD:6907045 |
KEGG |
| G |
Fdx1 |
ferredoxin 1 |
|
|
ISS |
8 |
55,291,396 |
55,310,507 |
RGD:2325883 |
RGD |
| G |
Fdxr |
ferredoxin reductase |
|
|
ISS |
10 |
105,342,684 |
105,351,374 |
RGD:2325883 |
RGD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
|
IEA |
13 |
109,063,491 |
109,089,468 |
RGD:6907045 |
KEGG |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
|
IEA |
19 |
35,336,342 |
35,341,585 |
RGD:6907045 |
KEGG |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
|
IEA |
10 |
90,094,249 |
90,096,451 |
RGD:6907045 |
KEGG |
| G |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
|
|
IEA |
3 |
78,436,634 |
78,559,707 |
RGD:6907045 |
KEGG |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
|
IEA |
19 |
47,729,519 |
47,802,933 |
RGD:6907045 |
KEGG |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
|
IEA |
17 |
6,554,164 |
6,585,525 |
RGD:6907045 |
KEGG |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
|
IEA |
7 |
1,118,183 |
1,137,670 |
RGD:6907045 |
KEGG |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
|
IEA |
13 |
85,776,077 |
85,792,977 |
RGD:6907045 |
KEGG |
| G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
|
|
IEA |
20 |
4,964,860 |
4,966,855 |
RGD:6907045 |
KEGG |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
|
IEA |
2 |
193,337,342 |
193,346,799 |
RGD:6907045 |
KEGG |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
|
ISS |
2 |
193,337,342 |
193,346,799 |
RGD:4889549 |
RGD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
|
ISS |
2 |
193,500,916 |
193,507,633 |
RGD:4889549 |
RGD |
| G |
Hsd3b5 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
|
|
IEA |
2 |
193,249,949 |
193,269,979 |
RGD:6907045 |
KEGG |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
ISS |
12 |
22,078,629 |
22,097,301 |
RGD:2325883 |
RGD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
|
IEA |
17 |
3,845,190 |
3,879,165 |
RGD:6907045 |
KEGG |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
|
IEA |
6 |
21,453,521 |
21,489,408 |
RGD:6907045 |
KEGG |
| G |
Srd5a3 |
steroid 5 alpha-reductase 3 |
|
|
IEA |
14 |
34,318,370 |
34,333,413 |
RGD:6907045 |
KEGG |
| G |
Star |
steroidogenic acute regulatory protein |
|
|
TAS |
16 |
70,642,580 |
70,647,203 |
RGD:2325883 |
RGD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
|
IEA |
X |
63,915,803 |
63,923,834 |
RGD:6907045 |
KEGG |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
|
IEA |
14 |
21,948,475 |
21,965,541 |
RGD:6907045 |
KEGG |
| G |
Sult2a2 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
|
|
IEA |
|
|
|
RGD:6907045 |
KEGG |
| G |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
|
|
IEA |
1 |
96,197,902 |
96,261,672 |
RGD:6907045 |
KEGG |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
|
IEA |
9 |
87,091,241 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
|
IEA |
9 |
87,081,132 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a3 |
UDP glycosyltransferase 1 family, polypeptide A3 |
|
|
IEA |
9 |
87,070,247 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
|
|
IEA |
9 |
87,052,169 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
|
IEA |
9 |
87,037,154 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
|
IEA |
9 |
87,029,500 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
|
IEA |
9 |
87,017,029 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
|
IEA |
9 |
86,986,915 |
87,098,362 |
RGD:6907045 |
KEGG |
| G |
Ugt2a1 |
UDP glucuronosyltransferase 2 family, polypeptide A1 |
|
|
IEA |
14 |
22,047,612 |
22,071,582 |
RGD:6907045 |
KEGG |
| G |
Ugt2a3 |
UDP glucuronosyltransferase 2 family, polypeptide A3 |
|
|
IEA |
14 |
22,099,350 |
22,116,820 |
RGD:6907045 |
KEGG |
| G |
Ugt2b |
UDP glycosyltransferase 2 family, polypeptide B |
|
|
IEA |
14 |
22,154,370 |
22,178,222 |
RGD:6907045 |
KEGG |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
|
IEA |
14 |
22,639,182 |
22,650,931 |
RGD:6907045 |
KEGG |
| G |
Ugt2b37 |
UDP-glucuronosyltransferase 2 family, member 37 |
|
|
IEA |
14 |
22,404,705 |
22,421,315 |
RGD:6907045 |
KEGG |
aldosterone biosynthetic pathway
|
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,793,976 |
61,805,308 |
RGD:4892309 |
RGD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
|
ISS |
7 |
112,977,395 |
112,984,080 |
RGD:4889549 |
RGD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
TAS |
7 |
113,043,365 |
113,049,779 |
RGD:4889549 |
RGD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
|
ISS |
20 |
4,125,357 |
4,128,518 |
RGD:4889549 |
RGD |
| G |
Fdx1 |
ferredoxin 1 |
|
|
ISS |
8 |
55,291,396 |
55,310,507 |
RGD:2325883 |
RGD |
| G |
Fdxr |
ferredoxin reductase |
|
|
ISS |
10 |
105,342,684 |
105,351,374 |
RGD:2325883 |
RGD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
ISS |
12 |
22,078,629 |
22,097,301 |
RGD:4892309 |
RGD |
| G |
Star |
steroidogenic acute regulatory protein |
|
|
ISS |
16 |
70,642,580 |
70,647,203 |
RGD:2325883 |
RGD |
C21-steroid hormone biosynthetic pathway
|
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
IDA |
7 |
113,043,365 |
113,049,779 |
RGD:727991 |
RGD |
| G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
|
|
IDA |
7 |
113,013,335 |
113,018,824 |
RGD:1299585 |
RGD |
cortisol biosynthetic pathway
|
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,793,976 |
61,805,308 |
RGD:4892309 |
RGD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
|
ISS |
7 |
112,977,395 |
112,984,080 |
RGD:4889549 |
RGD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
|
ISS |
1 |
251,965,458 |
251,971,449 |
RGD:4892309 |
RGD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
|
ISS |
20 |
4,125,357 |
4,128,518 |
RGD:4889549 |
RGD |
| G |
Fdx1 |
ferredoxin 1 |
|
|
ISS |
8 |
55,291,396 |
55,310,507 |
RGD:2325883 |
RGD |
| G |
Fdxr |
ferredoxin reductase |
|
|
ISS |
10 |
105,342,684 |
105,351,374 |
RGD:2325883 |
RGD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
|
ISS |
2 |
193,337,342 |
193,346,799 |
RGD:4889549 |
RGD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
|
ISS |
2 |
193,500,916 |
193,507,633 |
RGD:4889549 |
RGD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
ISS |
12 |
22,078,629 |
22,097,301 |
RGD:4892309 |
RGD |
| G |
Star |
steroidogenic acute regulatory protein |
|
|
ISS |
16 |
70,642,580 |
70,647,203 |
RGD:2325883 |
RGD |
estradiol biosynthetic pathway
|
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,793,976 |
61,805,308 |
RGD:4892309 |
RGD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
|
ISS |
1 |
251,965,458 |
251,971,449 |
RGD:4892309 |
RGD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
|
ISS |
|
|
|
RGD:2325883 |
RGD |
| G |
Fdx1 |
ferredoxin 1 |
|
|
ISS |
8 |
55,291,396 |
55,310,507 |
RGD:2325883 |
RGD |
| G |
Fdxr |
ferredoxin reductase |
|
|
ISS |
10 |
105,342,684 |
105,351,374 |
RGD:2325883 |
RGD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
|
TAS |
10 |
90,094,249 |
90,096,451 |
RGD:4889549 |
RGD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
|
ISS |
10 |
90,094,249 |
90,096,451 |
RGD:2325883 |
RGD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
|
ISS |
19 |
47,729,519 |
47,802,933 |
RGD:4889549 |
RGD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
|
ISS |
17 |
6,554,164 |
6,585,525 |
RGD:2325883 |
RGD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
|
ISS |
2 |
193,337,342 |
193,346,799 |
RGD:4889549 |
RGD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
|
ISS |
2 |
193,500,916 |
193,507,633 |
RGD:4889549 |
RGD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
ISS |
12 |
22,078,629 |
22,097,301 |
RGD:4892309 |
RGD |
| G |
Star |
steroidogenic acute regulatory protein |
|
|
ISS |
16 |
70,642,580 |
70,647,203 |
RGD:2325883 |
RGD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
|
ISS |
X |
63,915,803 |
63,923,834 |
RGD:6893583 |
RGD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
|
ISS |
14 |
21,948,475 |
21,965,541 |
RGD:6893583 |
RGD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
|
ISS |
1 |
75,632,632 |
75,708,022 |
RGD:2325883 |
RGD |
testosterone biosynthetic pathway
|
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,793,976 |
61,805,308 |
RGD:2325883 |
RGD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
|
ISS |
1 |
251,965,458 |
251,971,449 |
RGD:2325883 |
RGD |
| G |
Fdx1 |
ferredoxin 1 |
|
|
ISS |
8 |
55,291,396 |
55,310,507 |
RGD:2325883 |
RGD |
| G |
Fdxr |
ferredoxin reductase |
|
|
ISS |
10 |
105,342,684 |
105,351,374 |
RGD:2325883 |
RGD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
|
ISS |
19 |
47,729,519 |
47,802,933 |
RGD:4889549 |
RGD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
|
ISS |
17 |
6,554,164 |
6,585,525 |
RGD:2325883 |
RGD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
|
ISS |
2 |
193,337,342 |
193,346,799 |
RGD:4889549 |
RGD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
|
ISS |
2 |
193,500,916 |
193,507,633 |
RGD:4889549 |
RGD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
ISS |
12 |
22,078,629 |
22,097,301 |
RGD:2325883 |
RGD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
|
ISS |
17 |
3,845,190 |
3,879,165 |
RGD:2325883 |
RGD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
|
ISS |
6 |
21,453,521 |
21,489,408 |
RGD:2325883 |
RGD |
| G |
Star |
steroidogenic acute regulatory protein |
|
|
TAS |
16 |
70,642,580 |
70,647,203 |
RGD:2325883 |
RGD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
|
ISS |
X |
63,915,803 |
63,923,834 |
RGD:6893583 |
RGD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
|
ISS |
1 |
75,632,632 |
75,708,022 |
RGD:2325883 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the steroid hormone biosynthetic pathway
|
|
|
|
| Akr1d1 | Bile acid synthesis defect, congenital, 2 | | Comt | Brain Injuries , Breast Neoplasms , Carcinoma, Renal Cell , Catalepsy , Diabetes Mellitus, Experimental , DiGeorge Syndrome , Dyskinesia, Drug-Induced , Endometrial Neoplasms , Hypertension , Leiomyoma , Mammary Neoplasms, Animal , Obesity , Obsessive-Compulsive Disorder , Ovarian Neoplasms , Pain , Panic Disorder , Parkinsonian Disorders , Polycystic Ovary Syndrome , Prostatic Neoplasms , Schizophrenia , Urinary Bladder Neoplasms , Venous Thrombosis | | Cyp11a1 | Adrenal Hyperplasia, Congenital , Adrenal Insufficiency , Brain Injuries , Cardiomegaly , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Fetal Growth Retardation , Hyperglycemia , Hypertension , Hypogonadism , Nephrosis , Sciatic Neuropathy , Status Epilepticus | | Cyp11b1 | Adrenal Hyperplasia, Congenital , Adrenocortical Adenoma , Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency , Fetal Growth Retardation , Glucocorticoid-Remediable Aldosteronism , Hyperaldosteronism , Hypertension , Hypertrophy, Left Ventricular | | Cyp11b2 | 18-Hydroxylase deficiency , Acidosis, Renal Tubular , Adrenocortical Adenoma , Albuminuria , Cardiomegaly , Diabetes Mellitus , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Diabetic Nephropathies , Fetal Growth Retardation , Fibrosis , Heart Diseases , Heart Failure , Hyperaldosteronism , Hypertension , Hypertrophy, Left Ventricular , Hypoaldosteronism , Metabolic Syndrome X , Myocardial Infarction , Myocarditis , Pre-Eclampsia , Stroke | |
| Cyp17a1 | Adrenal Hyperplasia, Congenital , Adrenal hyperplasia, congenital, type 5 , Breast Neoplasms , Cholelithiasis , Gallbladder Neoplasms , Osteoporosis , Pancreatic Neoplasms , Polycystic Ovary Syndrome , Prostatic Neoplasms , Sciatic Neuropathy | | Cyp19a1 | Alzheimer Disease , Aromatase deficiency , Breast Neoplasms , Diabetes Mellitus, Experimental , Disorders of Sex Development , Endometrial Neoplasms , Gynecomastia , Hypertension , Hypogonadism , Hypothyroidism , Metabolism, Inborn Errors , Osteoporosis , Osteoporosis, Postmenopausal , Ovarian Neoplasms , Placental Insufficiency , Polycystic Ovary Syndrome , Protein-Energy Malnutrition , Reperfusion Injury | | Cyp1a1 | Acute Lung Injury , Arthritis, Psoriatic , Arthritis, Reactive , Asthma , Breast Neoplasms , Bronchitis , Bronchitis, Chronic , Colitis , Cystic Fibrosis , Diabetes Mellitus , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Digestive System Neoplasms , Endometrial Neoplasms , Endometriosis , Gallbladder Neoplasms , Graves Disease , Hyperoxia , Inflammation , Lung Neoplasms , Lupus Erythematosus, Systemic , Nematode Infections , Parkinson Disease , Parkinsonian Disorders , Pneumonia , Psoriasis , Pulmonary Disease, Chronic Obstructive , Reperfusion Injury , Sepsis , Sjogren's Syndrome , Spondylitis, Ankylosing | | Cyp1b1 | Glaucoma , Glaucoma 1, Open Angle, A , Glaucoma 3, Primary Congenital, A , Glaucoma, Primary Open Angle , Peters anomaly | | Cyp21a1 | Adrenal Hyperplasia, Congenital , Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | |
| Cyp3a23/3a1 | Depressive Disorder , Inflammation | | Cyp3a2 | Anxiety Disorders , Breast Neoplasms , Inflammation , Prostate cancer, familial , Subarachnoid Hemorrhage | | Cyp3a9 | Alzheimer Disease , Hypertension, Essential , Pediatric Crohn's disease | |
| Cyp7b1 | Liver Diseases , Metabolism, Inborn Errors , Spastic paraplegia type 5A, recessive | | Fdx1 | Pancreatitis | |
| Hsd11b1 | Diabetes Mellitus, Type 2 , Hyperlipidemias , Metabolic Syndrome X , Metabolism, Inborn Errors , Obesity | | Hsd11b2 | Diabetes Mellitus, Type 1 , Diabetes Mellitus, Type 2 , Fetal Growth Retardation , Hypertension , Metabolism, Inborn Errors , Myocardial Infarction , Obesity , Ureteral Obstruction | |
| Hsd17b1 | Breast Neoplasms | |
| Hsd17b3 | 17-Hydroxysteroid Dehydrogenase Deficiency , Alzheimer Disease , Diabetes Mellitus, Type 2 , Disorders of Sex Development | |
|
|
| Hsd3b1 | Hyperprolactinemia , Hypertension | | Hsd3b2 | Adrenal hyperplasia 2 , Adrenal Hyperplasia, Congenital , Alzheimer Disease , Diabetes Mellitus, Type 2 , Hyperprolactinemia , Hypertension , Hypogonadism , Hypospadias , Hypothyroidism , Polycystic Ovary Syndrome , Sciatic Neuropathy | |
| Por | Adrenal Hyperplasia, Congenital , ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS , Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency , Hypotension , Musculoskeletal Abnormalities , Neural Tube Defects | | Srd5a1 | Breast Neoplasms , Cardiomegaly , Diabetes Mellitus, Type 2 , Hyperprolactinemia , Hypothyroidism , Obesity , Prostatic Hyperplasia , Prostatic Neoplasms | | Srd5a2 | Breast Neoplasms , Diabetes Mellitus , Hyperprolactinemia , Hypospadias , Penis agenesis , Prostatic Neoplasms , Pseudovaginal perineoscrotal hypospadias , Urogenital Abnormalities | | Srd5a3 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq , Kahrizi Syndrome | | Star | Adrenal Hyperplasia, Congenital , Cardiomegaly , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Fetal Growth Retardation , Fever , Hypogonadism , Hypothyroidism , Lipoid congenital adrenal hyperplasia , Nephrosis , Polycystic Ovary Syndrome , Toe Syndactyly, Telecanthus, and Anogenital and Renal Malformations | | Sts | Cryptorchidism , Hypertension , Ichthyosis, X-Linked | | Sult1e1 | Breast Neoplasms , Endometrial Neoplasms , Neoplasm Metastasis , Reperfusion Injury | |
|
| Ugt1a1 | Breast Neoplasms , Cholelithiasis , Crigler Najjar syndrome, type 1 , Crigler Najjar syndrome, type 2 , Crigler-Najjar Syndrome , Crohn Disease , Diabetes Mellitus, Type 1 , Endometrial Neoplasms , Genital Neoplasms, Female , Gilbert Disease , Gram-Negative Bacterial Infections , Hyperbilirubinemia , Hyperbilirubinemia, Transient Familial Neonatal , Hyperthyroidism , Inflammation , Ovarian Neoplasms , Starvation | |
|
|
|
| Ugt1a7c | Pancreatic Neoplasms , Pancreatitis, Alcoholic | |
| Ugt1a9 | Cholangiocarcinoma | |
|
|
|
|
|
| Pancreatic Neoplasms | Cyp17a1 , Ugt1a7c | | Gram-Negative Bacterial Infections | Ugt1a1 | | Diabetes Mellitus | Cyp11b2 , Cyp1a1 , Srd5a2 | | Osteoporosis | Cyp17a1 , Cyp19a1 | | Hypospadias | Hsd3b2 , Srd5a2 | | Inflammation | Cyp1a1 , Cyp3a23/3a1 , Cyp3a2 , Ugt1a1 | | Fetal Growth Retardation | Cyp11b1 , Cyp11b2 , Hsd11b2 , Cyp11a1 , Star | | Metabolism, Inborn Errors | Cyp19a1 , Cyp7b1 , Hsd11b1 , Hsd11b2 | | Carcinoma, Renal Cell | Comt | | Hyperprolactinemia | Srd5a1 , Hsd3b1 , Hsd3b2 , Srd5a2 | | Glaucoma | Cyp1b1 | | Obesity | Comt , Hsd11b1 , Hsd11b2 , Srd5a1 | | Hypogonadism | Cyp19a1 , Cyp11a1 , Hsd3b2 , Star | | Bile acid synthesis defect, congenital, 2 | Akr1d1 | | Diabetes Mellitus, Type 2 | Cyp11b2 , Cyp1a1 , Hsd11b1 , Hsd11b2 , Srd5a1 , Cyp11a1 , Hsd17b3 , Hsd3b2 , Star | | Cholangiocarcinoma | Ugt1a9 | | Metabolic Syndrome X | Cyp11b2 , Hsd11b1 | | Musculoskeletal Abnormalities | Por | | Neural Tube Defects | Por | | Cardiomegaly | Cyp11b2 , Srd5a1 , Cyp11a1 , Star | | Cryptorchidism | Sts | | Urogenital Abnormalities | Srd5a2 | | Adrenal Insufficiency | Cyp11a1 | | Nephrosis | Cyp11a1 , Star | | Pseudovaginal perineoscrotal hypospadias | Srd5a2 | | Lung Neoplasms | Cyp1a1 | | Gallbladder Neoplasms | Cyp17a1 , Cyp1a1 | | Hypothyroidism | Cyp19a1 , Srd5a1 , Hsd3b2 , Star | | Colitis | Cyp1a1 | | Pain | Comt | | Pneumonia | Cyp1a1 | | Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency | Cyp11b1 | | Adrenal Hyperplasia, Congenital | Cyp11b1 , Cyp17a1 , Cyp21a1 , Star , Por , Cyp11a1 , Hsd3b2 | | Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | Cyp21a1 | | Ovarian Neoplasms | Comt , Cyp19a1 , Ugt1a1 | | Acidosis, Renal Tubular | Cyp11b2 | | Crigler Najjar syndrome, type 1 | Ugt1a1 | | Crigler-Najjar Syndrome | Ugt1a1 | | Crigler Najjar syndrome, type 2 | Ugt1a1 | | Fever | Star | | Pediatric Crohn's disease | Cyp3a9 | | Crohn Disease | Ugt1a1 | | Breast Neoplasms | Comt , Cyp17a1 , Cyp19a1 , Cyp1a1 , Hsd17b1 , Srd5a1 , Sult1e1 , Srd5a2 , Cyp3a2 , Ugt1a1 | | Bronchitis | Cyp1a1 | | Liver Diseases | Cyp7b1 | | Lupus Erythematosus, Systemic | Cyp1a1 | | Urinary Bladder Neoplasms | Comt | | Gynecomastia | Cyp19a1 | | Disorders of Sex Development | Cyp19a1 , Hsd17b3 | | Alzheimer Disease | Cyp19a1 , Hsd17b3 , Cyp3a9 , Hsd3b2 | | Penis agenesis | Srd5a2 | | Diabetes Mellitus, Type 1 | Hsd11b2 , Ugt1a1 | | Spastic paraplegia type 5A, recessive | Cyp7b1 | | Fibrosis | Cyp11b2 | | Psoriasis | Cyp1a1 | | Lipoid congenital adrenal hyperplasia | Star | | Cystic Fibrosis | Cyp1a1 | | Hypertension | Comt , Cyp11b1 , Cyp11b2 , Cyp19a1 , Hsd11b2 , Hsd3b1 , Cyp11a1 , Hsd3b2 , Sts | | Parkinson Disease | Cyp1a1 | | Parkinsonian Disorders | Comt , Cyp1a1 | | Prostate cancer, familial | Cyp3a2 | | Prostatic Neoplasms | Comt , Cyp17a1 , Srd5a1 , Srd5a2 | | Prostatic Hyperplasia | Srd5a1 | | Polycystic Ovary Syndrome | Comt , Cyp17a1 , Cyp19a1 , Hsd3b2 , Star | | Ichthyosis, X-Linked | Sts | | Ureteral Obstruction | Hsd11b2 | | Aromatase deficiency | Cyp19a1 | | 17-Hydroxysteroid Dehydrogenase Deficiency | Hsd17b3 | | 18-Hydroxylase deficiency | Cyp11b2 | | Hypoaldosteronism | Cyp11b2 | | Peters anomaly | Cyp1b1 | | Adrenal hyperplasia 2 | Hsd3b2 | | Adrenal hyperplasia, congenital, type 5 | Cyp17a1 | | Pre-Eclampsia | Cyp11b2 | | DiGeorge Syndrome | Comt | | Anxiety Disorders | Cyp3a2 | | Albuminuria | Cyp11b2 | | Heart Diseases | Cyp11b2 | | Asthma | Cyp1a1 | | Hyperaldosteronism | Cyp11b1 , Cyp11b2 | | Digestive System Neoplasms | Cyp1a1 | | Brain Injuries | Comt , Cyp11a1 | | Catalepsy | Comt | | Cholelithiasis | Cyp17a1 , Ugt1a1 | | Depressive Disorder | Cyp3a23/3a1 | | Diabetes Mellitus, Experimental | Comt , Cyp11b2 , Cyp19a1 , Cyp1a1 , Cyp11a1 , Star | | Diabetic Nephropathies | Cyp11b2 | | Dyskinesia, Drug-Induced | Comt | | Heart Failure | Cyp11b2 | | Endometriosis | Cyp1a1 | | Genital Neoplasms, Female | Ugt1a1 | | Gilbert Disease | Ugt1a1 | | Graves Disease | Cyp1a1 | | Hyperthyroidism | Ugt1a1 | | Venous Thrombosis | Comt | | Hyperbilirubinemia | Ugt1a1 | | Hyperlipidemias | Hsd11b1 | | Hyperglycemia | Cyp11a1 | | Hypotension | Por | | Protein-Energy Malnutrition | Cyp19a1 | | Nematode Infections | Cyp1a1 | | Leiomyoma | Comt | | Neoplasm Metastasis | Sult1e1 | | Mammary Neoplasms, Animal | Comt | | Myocardial Infarction | Cyp11b2 , Hsd11b2 | | Myocarditis | Cyp11b2 | | Obsessive-Compulsive Disorder | Comt | | Pancreatitis | Fdx1 | | Placental Insufficiency | Cyp19a1 | | Schizophrenia | Comt | | Sciatic Neuropathy | Cyp17a1 , Cyp11a1 , Hsd3b2 | | Sepsis | Cyp1a1 | | Sjogren's Syndrome | Cyp1a1 | | Spondylitis, Ankylosing | Cyp1a1 | | Starvation | Ugt1a1 | | Status Epilepticus | Cyp11a1 | | Subarachnoid Hemorrhage | Cyp3a2 | | Reperfusion Injury | Cyp19a1 , Cyp1a1 , Sult1e1 | | Arthritis, Psoriatic | Cyp1a1 | | Osteoporosis, Postmenopausal | Cyp19a1 | | Panic Disorder | Comt | | Endometrial Neoplasms | Comt , Cyp19a1 , Cyp1a1 , Sult1e1 , Ugt1a1 | | Arthritis, Reactive | Cyp1a1 | | Hypertrophy, Left Ventricular | Cyp11b1 , Cyp11b2 | | Adrenocortical Adenoma | Cyp11b1 , Cyp11b2 | | Hyperoxia | Cyp1a1 | | Pancreatitis, Alcoholic | Ugt1a7c | | Stroke | Cyp11b2 | | Pulmonary Disease, Chronic Obstructive | Cyp1a1 | | Bronchitis, Chronic | Cyp1a1 | | Acute Lung Injury | Cyp1a1 | | ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS | Por | | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq | Srd5a3 | | Hypertension, Essential | Cyp3a9 | | Hyperbilirubinemia, Transient Familial Neonatal | Ugt1a1 | | Glaucoma, Primary Open Angle | Cyp1b1 | | Glucocorticoid-Remediable Aldosteronism | Cyp11b1 | | Glaucoma 1, Open Angle, A | Cyp1b1 | | Glaucoma 3, Primary Congenital, A | Cyp1b1 | | Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency | Por | | Kahrizi Syndrome | Srd5a3 | | Toe Syndactyly, Telecanthus, and Anogenital and Renal Malformations | Star | |
|